Stochastic detection of enantiomers

Journal of the American Chemical Society

Volumn 128, Issue 33, 2006, Pages 10684-10685

  Kang, Xiao Feng ^a   Cheley, Stephen ^b   Guan, Xiyun ^c   Bayley, Hagan ^d  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; CYCLODEXTRIN; HUMAN SERUM ALBUMIN; IBUPROFEN; THALIDOMIDE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; CHIRALITY; ENANTIOMER; ENANTIOSELECTIVITY; ISOMER; KINETICS; LIPID BILAYER; MEMBRANE POTENTIAL; MOLECULAR MODEL; NEUROPROTECTION; RACEMIZATION; SIGNAL DETECTION;

BETA-CYCLODEXTRINS; HEMOLYSIN PROTEINS; IBUPROFEN; MEMBRANES, ARTIFICIAL; MOLECULAR STRUCTURE; MUTATION; THALIDOMIDE;

EID: 33747758697     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja063485l     Document Type: Article

References (32)

1. Eriksson, T.; Bjorkman, S.; Hoglund, P. Eur. J. Clin. Pharmacol. 2001, 57, 365-376.
2. Ranade, V. V.; Somberg, J. C. Am. J. Ther. 2005, 12, 439-459.
3. Hao, H.; Wang, G.; Sun, J. Drug Metab. Rev. 2005, 37, 215-234.
4. Zhang, Y.; Wu, D. R.; Wang-Iverson, D. B.; Tymiak, A. A. Drug Discovery Today 2005, 10, 571-577.
5. Wolf, C. Chem. Soc. Rev. 2005, 34, 595-608.
6. Pu, L. Chem. Rev. 2004, 104, 1687-1716.
7. Finn, M. G. Chirality 2002, 14, 534-540.
8. Hofstetter, O.; Hofstetter, H.; Wilchek, M.; Schurig, V.; Green, B. S. Nat. Biotechnol. 1999, 17, 371-374.
9. (a) Lopinski, G. P.; Moffatt, D. J.; Wayner, D. D. M.; Wolkow, R. A. Nature 1998, 392, 909-911.
10. (b) Fang, H.; Giancario, L. C.; Flynn, G. W. J. Phys. Chem. B 1998, 102, 7311-7315.
11. Bayley, H.; Cremer, P. S. Nature 2001, 413, 226-230.
12. Gu, L.-Q.; Braha, O.; Conlan, S.; Cheley, S.; Bayley, H. Nature 1999, 398, 686-690.
13. Gu, L.-Q.; Cheley, S.; Bayley, H. J. Gen. Physiol. 2001, 118, 481-494.
14. Song, L.; Hobaugh, M. R.; Shustak, C.; Cheley, S.; Bayley, H.; Gouaux, J. E. Science 1996, 274, 1859-1865.
15. Hawel, R.; Klein, G.; Singer, F.; Mayrhofer, F.; Kahler, S. T. Int. J. Clin. Pharmacol. Ther. 2003, 41, 153-164.
16. Casper, D.; Yaparpalvi, U.; Rempel, N.; Werner, P. Neurosci. Lett. 2000, 289, 201-204.
17. Pina-Vaz, C.; Rodrigues, A. G.; Costa-de-Oliveira, S.; Ricardo, E.; Mardh, P. A. J. Antimicrob. Chemother. 2005, 56, 678-685.
18. Arai, R.; Sugita, T.; Nishikawa, A. Mycoses 2005, 48, 38-41.
19. Matthews, S. J.; McCoy, C. Clin. Ther. 2003, 25, 342-395.
20. Jacobson, J. M. Expert Opin. Pharmacother. 2000, 1, 849-863.
21. Hoglund, P.; Eriksson, T.; Bjorkman, S. J. Pharmacokinet. Biopharm. 1998, 26, 363-383.
22. (21 ) Wnendt, S.; Finkam, M.; Winter, W.; Ossig, J.; Raabe, G.; Zwingenberger, K. Chirality 1996, 8, 390-396.
23. Chung, F.; Palmer, B. D.; Muller, G. W.; Man, H. W.; Kestell, P.; Baguley, B. C.; Ching, L. M. Oncol. Res. 2003, 14, 75-82.
24. Knoche, B.; Blaschke, G. J. Chromatogr. A 1994, 666, 235-240.
25. Reist, M.; Carrupt, P.-A.; Francotte, E.; Testa, B. Chem. Res. Toxicol. 1998, 11, 1521-1528.
26. Chuang, V. T.; Otagiri, M. Chirality 2006, 18, 159-166.
27. Simard, J. R.; Zunszain, P. A.; Ha, C. E.; Yang, J. S.; Bhagavan, N. V.; Petitpas, I.; Curry, S.; Hamilton, J. A. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17958-17963.
28. Rekharsky, M. V.; Yamamura, H.; Kawai, M.; Inoue, Y. J. Org. Chem. 2003, 68, 5228-5235.
29. Rekharsky, M.; Inoue, Y. J. Am. Chem. Soc. 2002, 124, 813-826.
30. Rekharsky, M.; Inoue, Y. J. Am. Chem. Soc. 2000, 122, 4418-4435.
31. Gu, L.-Q.; Bayley, H. Biophys. J. 2000, 79, 1967-1975.
32. Braha, O.; Gu, L.-Q.; Zhou, L.; Lu, X.; Cheley, S.; Bayley, H. Nat. Biotechnol. 2000, 17, 1005-1007.